ArticleAnnals of transplantation2025
Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance.
Article in Annals of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND The incidence of ABO-incompatible (ABO-i) kidney transplantation (KT) is increasing. Furthermore, it has a higher early mortality rate than ABO-compatible (ABO-c) KT, which is largely attributed to the extensive use of immunosuppressive agents. While steroid use in patients with ABO-c KT is being reduced, this effort is less prevalent in patients with ABO-i KT. Therefore, our study investigated the specific impact of steroid withdrawal on graft survival in patients with ABO-i KT. MATERIAL AND METHODS This study evaluated 33 patients who underwent ABO-i KT. The primary outcome was biopsy-proven acute rejection. The secondary outcomes were graft function, infection, new-onset diabetes mellitus after transplantation (NODAT), and delayed graft function. RESULTS In an average follow-up period of 57.0±23.7 months, the cumulative probabilities of biopsy-proven rejection at 3 years post-transplantation were 30.8% in the steroid maintenance group and 40.0% in the steroid withdrawal group, with no significant difference (hazard ratio, 1.11; 95% confidence interval 0.32-3.9; P=0.648). Graft function was similar between the 2 groups. Steroid withdrawal did not affect the rates of infection, NODAT, osteoporosis, cardiovascular disease, BK virus viremia, or cytomegalovirus viremia. CONCLUSIONS Steroid withdrawal did not differ from steroid maintenance in the rate of rejection or graft function due to any cause.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.